<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="de">
	<id>http://dustlikestars.de/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=MaynardWeir58</id>
	<title>Erkenfara - Benutzerbeiträge [de]</title>
	<link rel="self" type="application/atom+xml" href="http://dustlikestars.de/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=MaynardWeir58"/>
	<link rel="alternate" type="text/html" href="http://dustlikestars.de/index.php?title=Spezial:Beitr%C3%A4ge/MaynardWeir58"/>
	<updated>2026-06-24T10:51:21Z</updated>
	<subtitle>Benutzerbeiträge</subtitle>
	<generator>MediaWiki 1.32.2</generator>
	<entry>
		<id>http://dustlikestars.de/index.php?title=Involuntary_Intoxication_Caused_By_Vaping_The_Synthetic_Cannabinoid_ADB-BUTINACA:_A_Case_Report&amp;diff=101665</id>
		<title>Involuntary Intoxication Caused By Vaping The Synthetic Cannabinoid ADB-BUTINACA: A Case Report</title>
		<link rel="alternate" type="text/html" href="http://dustlikestars.de/index.php?title=Involuntary_Intoxication_Caused_By_Vaping_The_Synthetic_Cannabinoid_ADB-BUTINACA:_A_Case_Report&amp;diff=101665"/>
		<updated>2026-05-26T07:00:48Z</updated>

		<summary type="html">&lt;p&gt;MaynardWeir58: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;4. Drugs &amp;lt;br&amp;gt;In general, the locomotor depressant and discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC. Subsequently, a one-way analysis of variance was conducted on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval. Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor.&amp;lt;br&amp;gt;Michael B Gatch &amp;lt;br&amp;gt;Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the [https://cannabinoidsrc4f-adb.com/ 5CLADBA] highest dose tested (0.5 mg/kg).&amp;lt;br&amp;gt;Figure 1. &amp;lt;br&amp;gt;There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016). As previously mentioned, all of the compounds tested in the present study (MDMB-PINACA, MDMB-CHMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA) act as agonists at CB1 receptors (Banister et al., 2015, 2016; Gamage et al., 2018), which suggests these compounds will produce Δ9-THC-like effects, including abuse liability. Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the mice.&amp;lt;br&amp;gt;Michael B Gat&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;When clinical presentation and/or initial DOA testing results are inconclusive, additional testing with LC-QTOF-MS can be valuable and is recommended. SCRAs and other NPS may not be detected by point-of-care DOA tests. In this case, the point-of-care DOA urine screening was not able to detect the synthetic cannabinoid ADB-BUTINAC&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Observation item 1st injection 2nd injection 3rd injection 4th injection 5th injection Con. All groups treated with tested synthetic cannabinoids showed decreased weight gain rate in a dose-dependent manner. A total of 5 mice in the JWH-081 (5 mg/kg, i.p.) treated group and 6 mice in the 5CLADBA JWH-210 (5 mg/kg, i.p.) treated group showed loss of traction, of which 4 and 5 showed tremor, respectively. Memory retention was measured after the memory acquisition was tested as a probe trial.&amp;lt;br&amp;gt;About Powder JWH-2&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;§ (3) of the Hungarian act of Forensic Experts (2016.XXIX), the data of the reported case can be utilized freely for scientific and educational purposes without special ethical permission. These results indicate that the simultaneous intoxication of SCRA and ethanol directly and exclusively caused the death of the two victims. The victims did not have any significant diseases that could have contributed to the outcome. Very limited data are available in the scientific literature about the possible effects of the combined consumption of SCRAs and ethanol. Several case reports describe that the presence of a little ng/mL (0.37–4.1) of SCRAs and a high—but not lethal—concentration of ethanol (1.45–2.7 g/L) directly and exclusively contributed to the death of the victim [24–27] (Table 2). The fact that 4F-MDMB-BINACA was not detected in postmortem urine samples is partly explained by the high rate of hepatic metabolism of SCRAs [11, 14, 22], but also suggests that the victims consumed 4F-MDMB-BINACA shortly before their death&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Legal status &amp;lt;br&amp;gt;Briefly, the FOB test was comprised of several behavioral changes including catalepsy, traction, tremor, convulsion, exopthalmos, piloerection, salivation, lacrimation, diarrhea, skin coloration, pinna reflex, righting reflex, and death. The FOB test was performed using published procedures (Moser et al., 1989) with some modifications. However, because of their subjective properties, it is necessary to set up a more objective automated measurement to determine their neurotoxicity. However, there are only a couple of anecdotal reports suspecting the possibility of their neurotoxicity with no scientific evidence (Cohen et al., 2012; McGuinness and Newell, 2012; Harris and Brown, 2013; Hermanns et al., 2013&lt;/div&gt;</summary>
		<author><name>MaynardWeir58</name></author>
		
	</entry>
	<entry>
		<id>http://dustlikestars.de/index.php?title=Benutzer:MaynardWeir58&amp;diff=101664</id>
		<title>Benutzer:MaynardWeir58</title>
		<link rel="alternate" type="text/html" href="http://dustlikestars.de/index.php?title=Benutzer:MaynardWeir58&amp;diff=101664"/>
		<updated>2026-05-26T07:00:43Z</updated>

		<summary type="html">&lt;p&gt;MaynardWeir58: Die Seite wurde neu angelegt: „34 years old Project Manager Danielle Simon, hailing from Keswick enjoys watching movies like Melancholia and Cycling. Took a trip to Historic Fortified Town o…“&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;34 years old Project Manager Danielle Simon, hailing from Keswick enjoys watching movies like Melancholia and Cycling. Took a trip to Historic Fortified Town of Campeche and drives a C70.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Look into my homepage ... [https://cannabinoidsrc4f-adb.com/ 5CLADBA]&lt;/div&gt;</summary>
		<author><name>MaynardWeir58</name></author>
		
	</entry>
</feed>